Loading organizations...
Sonavex, Inc. has raised $6.0M across 2 funding rounds.
Key people at Sonavex, Inc..
Sonavex, Inc. has raised $6.0M in total across 2 funding rounds.
Sonavex, Inc. develops advanced medical devices, specializing in novel ultrasound solutions that deliver critical visual and quantitative data. The company's core offerings include EchoMark, a bioresorbable implant used to mark at-risk blood vessels, and EchoSure, a deep-learning enabled 3D automated ultrasound device. These technologies empower healthcare providers to easily assess and monitor blood flow and vessel morphology, aiding in the identification and management of potential complications.
The company was founded in 2013, originally spun out of Johns Hopkins University, an insight that leveraged academic research into practical medical applications. Key figures involved in the company's early development include Jerry Prince, a distinguished professor, and David Narrow, who leads the company as CEO. Their work focused on translating sophisticated ultrasound imaging techniques into accessible, actionable tools for clinical settings.
Sonavex's products primarily serve healthcare professionals in areas such as dialysis access care, enabling better patient outcomes and more efficient clinical workflows. The company's overarching vision is to advance "Empowered Patient Care" by providing clinicians with precise, objective data at the point of care, thereby enhancing diagnostic capabilities and improving long-term patient health management.
Sonavex, Inc. has raised $6.0M across 2 funding rounds. Most recently, it raised $3.0M Sonavex - Other Equity in November 2019.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 5, 2019 | $3M Venture Round | — | Texas Medical Center | Announced |
| Apr 24, 2017 | $3M Grant | Grey SKY Venture Partners | Abell Foundation, CRCM Ventures, National Science Foundation, TEDCO | Announced |
Sonavex, Inc. has raised $6.0M in total across 2 funding rounds.
Sonavex, Inc.'s investors include Texas Medical Center, Grey Sky Venture Partners, Abell Foundation, CRCM Ventures, National Science Foundation, TEDCO.
Key people at Sonavex, Inc..
Sonavex, Inc. is a Baltimore-based medical device company that builds ultrasound-based products (EchoMark and EchoSure) to enable simple, quantitative monitoring of arteriovenous fistula (AVF) blood flow and vascular parameters for dialysis patients, with the goal of improving fistula maturation, reducing catheter use and complications, and lowering care costs[6][1].
High-Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech and Health Landscape
Quick Take & Future Outlook
Quick take: Sonavex is a Johns Hopkins spinout translating ultrasound + AI into a focused, clinic‑centric solution for dialysis vascular access monitoring; its near‑term trajectory hinges on pivotal trial results, regulatory clearances, and demonstrated cost‑outcomes that will determine whether the technology becomes a standard tool in dialysis care[6][5].